Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Annals of Surgical Oncology|March 29, 2018
Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN)Mohammad Al Efishat, Marc A Attiyeh, Anne A Eaton, et al.The Lancet. Oncology|September 16, 2015
Consensus on biomarkers for neuroendocrine tumour diseaseKjell Oberg, Irvin M Modlin, Wouter De Herder, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular OverlapSarah E Umetsu, Sanjay Kakar, Olca Basturk, et al.Annals of Surgery|June 27, 2008
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resectionItaru Endo, Mithat Gonen, Adam C Yopp, et al.JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.Gastrointestinal Cancer Research : GCR|March 19, 2013
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortiumCelina S Ang, R Katie Kelley, Michael A Choti, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2026
Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer PrecursorMichele Bevere, Antonio Pea, Volkan Adsay, et al.Hepatology (Baltimore, Md.)|January 24, 2018
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentationElizabeth Brunt, Shinichi Aishima, Pierre-Alain Clavien, et al.Journal of the American Medical Informatics Association : JAMIA|July 14, 2021
Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical centerPeter J Schüffler, Luke Geneslaw, D Vijay K Yarlagadda, et al.Nature Genetics|November 5, 2013
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasYuchen Jiao, Timothy M Pawlik, Robert A Anders, et al.Pageof 7